Murphy Martin Patrick bought IPSC
December 9, 2025 · Form 4 insider transaction
Murphy Martin Patrick bought 88,000 shares of Century Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 122 days after the transaction.
Direction
Acquired (buy-side)
Shares
88,000
Price
$0.00
Total value
N/A
InsiderMurphy Martin Patrick
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateDecember 9, 2025
Filing dateApril 10, 2026
Shares owned after88,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Century Therapeutics, Inc. (the "Company") issued to the Reporting Person stock options (the "Options") in connection with his appointment as a director. The Options vest in equal monthly installments over 36 months subject to the Reporting Person's continued service to the Company and are issued pursuant to the Company's 2021 Equity Incentive Plan.